Abstract
CD3CD56+ natural killer (NK) cells can kill various tumors in a non major histocompatibility complex (MHC)-restricted fashion. Recent advances have been made in the application of NK cells for the treatment of patients with acute myelogenous leukemia (AML). Allogeneic donor-derived NK cells can be activated in vitro and infused into patients receiving stem cell transplants. We describe in this chapter the method to activate NK cells with cytokines and to ascertain their degree of activation.
| Original language | English |
|---|---|
| Pages (from-to) | 223-229 |
| Number of pages | 7 |
| Journal | Methods in Molecular Biology |
| Volume | 1139 |
| DOIs | |
| State | Published - 2014 |
Bibliographical note
Publisher Copyright:© Springer Science+Business Media New York 2014.
Keywords
- Cytokines
- Interleukin-15
- Natural killer cells